17 February 2020
For the first time, EMA is making suspected side effect reports of veterinary medicines authorised in the European Union publicly accessible through the www.adrreports.eu website. The reports come directly from Eudravigilance Veterinary (EVVet), a database for processing pharmacovigilance reports which is used as one of several tools for regulators to monitor the benefit-risk balance of a veterinary medicine once it is authorised.
Suspected side effects are usually observed by veterinarians or pet owners. They are submitted electronically to EVVet – that collects reports of suspected serious adverse events in the EU as well as outside the EU – by national competent authorities or marketing authorisation holders.
The data published on www.adrreports.eu refers to approximately 250 centrally authorised veterinary medicines.
Making this information publicly available allows EMA’s stakeholders, including the general public, to access important data used by European regulatory authorities to review the safety of a veterinary medicine or active substance.
Upon accessing the website, web reports on adverse events can be searched by product name (for centrally authorised veterinary medicines) or by active substance. The data displayed pulls together the total number of individual serious spontaneous cases reported.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024